26 March 2015 – Global organizations and the public are invited to provide inputs into upcoming Global Health Sector Strategies for HIV, Viral Hepatitis and Sexually Transmitted Infections. The survey is available from the link below and is open to receive comments until 30 April 2015. More information on the Strategies' development process as well as background documents are also made available.
12 April 2015 - The WHO guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection released today provide comprehensive recommendations for the clinical management of hepatitis B infection. Globally, 240 million people have chronic hepatitis B, and without access to simplified and affordable services many of them could develop cirrhosis or liver cancer. The guidelines are intended for clinicians who care for people living with chronic hepatitis B and for country programme managers to help developing and scaling up hepatitis B services.
26 February 2015 – WHO welcomes results presented at the annual Conference on Retroviruses and Opportunistic Infections (CROI) 2015 on using antiretrovirals (ARVs) in pre-exposure prophylaxis (PrEP) and treatment of HIV infection. Results from the TEMPRANO trial, conducted in Western Africa, have confirmed – for the first time in a randomized controlled trial – the individual health benefits for people who start antiretroviral therapy (ART) immediately after diagnosis.
24 February 2015 – WHO has launched a new policy on injection safety, which recommends the use of “smart” syringes that cannot be used more than once. “Adoption of safety-engineered syringes is absolutely critical to protecting people worldwide from becoming infected with HIV, hepatitis and other diseases. This should be an urgent priority for all countries,” says Dr Gottfried Hirnschall, Director of the WHO HIV/AIDS Department. The policy also aims to better control the spread of infections and to reduce the number of unnecessary injections that are leading to more infections.
11.7 million At the end of 2013, 11.7 million people had access to antiretroviral therapy in low- and middle-income countries.Fact sheet on HIV/AIDS
35 millionAt the end of 2013, 35 million people were living with HIV.Online Q&A about HIV/AIDS
28 million Over 28 million people are eligible for antiretroviral therapy, under WHO 2013 consolidated ARV guidelines.10 facts on HIV
24 February 2015
16-18 February 2015
5 February 2015